ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study.

Edward B Garon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.